Ahmed A Rabie
Overview
Explore the profile of Ahmed A Rabie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabie A, Elhazmi A, Azzam M, Abdelbary A, Labib A, Combes A, et al.
Ann Intensive Care
. 2023 May;
13(1):36.
PMID: 37129771
Background: The high-quality evidence on managing COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support is insufficient. Furthermore, there is little consensus on allocating ECMO resources when scarce. The paucity of...
2.
Elhazmi A, Rabie A, Al-Omari A, Mufti H, Sallam H, Alshahrani M, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983304
Background: Tocilizumab is a monoclonal antibody proposed to manage cytokine release syndrome (CRS) associated with severe COVID-19. Previously published reports have shown that tocilizumab may improve the clinical outcomes of...
3.
Supady A, Combes A, Barbaro R, Camporota L, Diaz R, Fan E, et al.
Intensive Care Med
. 2022 Aug;
48(10):1326-1337.
PMID: 35945343
Extracorporeal membrane oxygenation (ECMO) is increasingly being used for patients with severe respiratory failure and has received particular attention during the coronavirus disease 2019 (COVID-19) pandemic. Evidence from two key...
4.
Elhazmi A, Al-Omari A, Sallam H, Mufti H, Rabie A, Alshahrani M, et al.
J Infect Public Health
. 2022 Jun;
15(7):826-834.
PMID: 35759808
Background: Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently a major cause of intensive care unit (ICU) admissions globally. The role...
5.
Rabie A, Azzam M, Al-Fares A, Abdelbary A, Mufti H, Hassan I, et al.
Intensive Care Med
. 2021 Jun;
47(8):887-895.
PMID: 34156477
Purpose: Extracorporeal membrane oxygenation (ECMO) use for severe coronavirus disease 2019 (COVID-19) patients has increased during the course of the pandemic. As uncertainty existed regarding patient's outcomes, early guidelines recommended...
6.
Mufti H, Rabie A, Elhazmi A, Bahaudden H, Rajab M, Al Enezi I, et al.
Saudi Med J
. 2021 Jun;
42(6):589-611.
PMID: 34078721
Extracorporeal membrane oxygenation (ECMO) is considered as a supportive treatment that provides circulatory and ventilatory support and can be thought off as a bridge to organ recovery. Since 2009, it...
7.
Badulak J, Antonini M, Stead C, Shekerdemian L, Raman L, Paden M, et al.
ASAIO J
. 2021 Mar;
67(5):485-495.
PMID: 33657573
This is an updated guideline from the Extracorporeal Life Support Organization (ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with severe cardiopulmonary failure due to coronavirus disease...
8.
Rabie A, Asiri A, Rajab M, Mufti H, Alsherbiny M, Azzam M, et al.
ASAIO J
. 2021 Feb;
67(3):339-344.
PMID: 33627610
Extracorporeal membrane oxygenation (ECMO) use in acute respiratory failure is increasing. We aim to compare characteristics and outcomes of patients with prolonged (≥21 days) veno-venous (VV) ECMO runs (pECMO), to...